Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial.

Williams LR. et al, (2024), Vaccine

Characterising the molecular epidemiology of human parechovirus in young infants in the UK and Canada.

Kadambari S. et al, (2024), J Clin Virol, 174

Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.

Dyson ZA. et al, (2024), Lancet Microbe

Improved estimates of COVID-19 correlates of protection, antibody decay and vaccine efficacy waning: a joint modelling approach

Phillips DJ. et al, (2024)

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.

Feng S. et al, (2024), Health Technol Assess, 28, 1 - 109

Inflammation of the Nasal Mucosa is Associated with Susceptibility to Experimental Pneumococcal Challenge in Older Adults.

Urban BC. et al, (2024), Mucosal Immunol

Towards paratyphoid control: the vital role of the challenge model

McCann N. et al, (2024), The Lancet, 403, 2780 - 2781

Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.

Costa Clemens SA. et al, (2024), Lancet Microbe

Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.

Kandasamy R. et al, (2024), Vaccine

The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.

Maytum A. et al, (2024), Pediatr Infect Dis J

A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial

Dinh Thiem V. et al, (2024), Vaccine

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.

Iwata S. et al, (2024), Sci Rep, 14

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.

Jackson S. et al, (2024), Lancet Microbe

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.

Drury RE. et al, (2024), Nat Commun, 15

Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.

GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), Lancet Infect Dis

Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine.

Cotugno N. et al, (2024), JCI Insight, 9

Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT

Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53

Typhoid conjugate vaccines: a step towards typhoid control

Shakya M. and Pollard AJ., (2024), The Lancet Global Health, 12, e535 - e536

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.

Kulkarni PS. et al, (2024), Lancet

Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology.

Martin NG. et al, (2024), J Infect, 88

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?